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Introduction
A.S.K Powder is a generic veterinary drug manufactured by 
Pharmacare pharmaceutical company (Palestine). The A.S.K powder is 
mainly used for the treatment and control of coccidiosis disease. It is 
very similar in composition to Amprocoxin-silv® that is manufactured 
by Silvavet Company for veterinary medicines.
The A.S.K powder comprises Amprolium hydrochloride, 
Sulfaquinoxaline sodium and Vitamin K3 sodium bisulfite (as 
menadione sodium bisulfite). 
As shown in Figure 1, the three active ingredients of the A.S.K 
Powder are very hydrophilic and possess polar basic or acidic character. 
Therefore, under most circumstances, they would elute within the 
column void volume, thus resulting in a significant challenge to keep 
them retained when using reversed phase chromatography.
In order to enhance their retention without using derivatization 
methodologies or adding ion-pair reagent to the mobile phase, a new 
HPLC method which is based on zwitterionic hydrophilic interaction 
liquid chromatography (ZIC-HILIC) coupled with ultraviolet detection 
has been optimized and validated.
To our knowledge, there is no quality control method neither in the 
official Pharmacopoeias nor in the literature, that determines the drug 
active ingredients simultaneously and therefore A.S.K Powder was not 
registered at the Ministry of Health of Palestine till now. 
There are different non-chromatographic and chromatographic 
methods, particularly RP-HPLC and ion-pair RP-HPLC, which 
report about the assay of each active ingredient individually or when 
present in combinations with other ingredients [1-17]. Some of these 
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Abstract
A new HPLC method that is based on zwitterionic hydrophilic interaction liquid chromatography (ZIC-HILIC) 
coupled with ultraviolet detection was developed, optimized and validated for the simultaneous determination of 
amprolium hydrochloride, sulfaquinoxaline sodium, and Vitamin K3 (as menadione sodium bisulfite) in A.S.K powder. 
The separation was carried out using ZIC-HILIC column (250 mm × 4.6 mm, 5 mm) and a mobile phase of 0.2 M 
Ammonium acetate (NH4AC) buffer and acetonitrile (15:85; v/v) with pH adjusted to 5.7 by glacial acetic acid at a 
flow rate of 0.5 ml/min. The analytes were monitored by UV detection at 263 nm.
The effects of the operational chromatographic conditions on retention and resolution were tested. Different 
concentrations of the organic solvent in the mobile phase, the ionic strength of the NH4AC buffer and pH of the 
mobile phase were investigated. 
The optimized method was subjected to validation by examining specificity, accuracy, precision, linearity, range, 
ruggedness and robustness. The results were evaluated as per the International Conference on Harmonization 
(ICH) and United States Pharmacopoeia (USP33/NF28) guidelines and it fulfilled the validation criteria. The method 
is sensitive, specific, fast, accurate, and requires minimum sample manipulation. It was applied on commercial A.S.K 
batches, to which all the active ingredients were separated from their excipients.
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Figure 1: The chemical structures for the three active ingredients in A.S.K 
Powder.
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methods suffer from drawback of using ion-pair reagents which include 
sensitivity reduction, extended time to reach equilibration, cleaning 
and regeneration of the column. 
Therefore, there is a need to develop a fast, specific, and accurate 
method that allows the simultaneous determination of the three 
active ingredients within a reasonable retention time as per ICH/USP 
validation norms [18,19] (Figure 1).
Experimental Details
Chemicals
Samples of amprolium hydrochloride, sulfaquinoxaline sodium, 
vitamin K3 sodium bisulfite reference standards were purchased from 
Sigma-Aldrich (Germany). Ammonium acetate extra pure, acetic 
acid (glacial), acetonitrile (ACN) and methanol HPLC grade solvents, 
hexane-1-sulfonic acid sodium salt and decane-1-sulfonic acid sodium 
salt were purchased from Merck (Germany).
High purified water was prepared by using a Millipore Milli-Q plus 
water purification system. 
A.S.K Powder samples, and all the active ingredients and excipients 
usually used in manufacturing the pharmaceutical combination, were 
kindly supplied by Pharmacare pharmaceutical company, Palestine.
Equipments
Elite Lachrom high performance liquid chromatograph equipped 
with uv-detector and supported with autosampler and column oven 
and Elite Lachrom data system of Agilent (Merck Hitachi, England).
The Ultraviolet/visible spectrometer (PG Instruments, United 
Kingdom).
Chromatographic conditions
The chromatographic column used was a ZIC-HILIC column (25.0 
cm × 4.6 mm) with particle size of 5 μm (Merck, Germany) protected 
with a ZIC-HILIC guard column (20 mm × 2.1 mm, 5 µm). 
0.2 M ammonium acetate solution was prepared by dissolving 3.08 
g of NH4AC in purified water and diluted up to 200 ml with the same 
solvent.
The optimum mobile phase selected for the assay was prepared by 
mixing 0.2 M NH4AC and acetonitrile (ACN) (15:85; v/v), shaken well 
and left tell the temperature of the mobile phase reached to the room 
temperature. Then the pH was adjusted to 5.7 by glacial acetic acid. 
The mobile phase was filtered using 0.45 µm microporous filter and was 
degassed by sonication prior to use. The standard and sample solutions 
were also filtered using 0.45 µm membrane filter.
A wavelength of 263 nm was chosen since it was found the most 
appropriate for the determination of the three active ingredients 
simultaneously. The flow rate used was 0.5 ml/minute as recommended 
by the column manufacturer whereby minimum height equivalent 
of theoretical plates and maximum number of theoretical plates are 
expected to be generated.
The injection volume was 20 µl and the temperature of the auto-
sampler was 15°C and that of the column was 25° C. Total run time was 
about 18 minutes. 
Preparation of stock and standard solutions
Stock solution for menadione sodium bisulfite was prepared by 
dissolving menadione sodium bisulfite reference standard equivalent to 
20 mg menadione (vitamin K3) in 80.0 ml of 90% ACN and diluting up 
to 100.0 ml with the same solvent. 5 ml of this solution was diluted up 
to 50 ml with 90% ACN to yield a solution with a final concentration 
of 20.0 µg/ml. 
Standard solutions for amprolium HCl, sulfaquinoxaline sodium 
and vitamin K3 were prepared by dissolving 20.0 mg of amprolium 
hydrochloride reference standard, 20 mg sulfaquinoxaline sodium 
reference standard in 70.0 ml of 90% ACN, 10 ml of menadione 
sodium bisulfite stock solution was added, mixed well and then 
diluted to 100.0 ml with 90% ACN. 5 ml of this solution was diluted 
up to 50 ml with mobile phase. The solution was filtered using 0.45 
µm membrane filter. The obtained final solution contains 20 µg/ml 
for amprolium hydrochloride, 20 µg/ml sulfaquinoxaline sodium 
and 0.20 µg/ml vitamin K3. This solution has been used within 24 
hours and kept at 15°C and was protected from light. 
Preparation of sample solution
Sample solution was prepared by dissolving 100 mg of A.S.K 
Powder in 80 ml of 90% ACN and then diluted up to 100 ml with the 
same solvent. Then 5 ml of the solution was diluted up to 50 ml with 
mobile phase. The latter solution was filtered using 0.45 µm membrane 
filter. The obtained final solution contains 20 µg/ml for amprolium 
hydrochloride, 20 µg/ml sulfaquinoxaline sodium and 0.20 µg/ml 
vitamin K3. This solution has been used within 24 hours and kept at 
15°C and was protected from light.
Results and Discussion 
Development and optimization of the ZIC-HILIC-HPLC 
method
Since the combined active ingredients are highly hydrophilic, at 
first we have tried the ion pair RP-chromatography mode using sodium 
1-hexanesulfonate and decane-1-sulfonic acid sodium salts at different 
concentration levels. Poor peak profile shapes with small resolution 
(Rs) values were obtained. Moreover, the ion pair reagents decreased 
the assay sensitivity for all ingredients particularly vitamin K3 since 
it is present at 0.2% level of the overall mixture concentration. This 
unsatisfactory start, lead us to switch to ZIC-HILIC column which is 
designed to overcome the shortcomings of the ion-pair mode when 
separating very polar compounds in reversed phase chromatography.
The overlaid ultraviolet absorption spectra of the three active 
ingredients demonstrated that they shared a wavelength near to 263 
nm, and therefore it was chosen during the entire study. 
Different mobile phases have been employed in order to optimize 
the desired HPLC method using HILIC column. These mobile phases 
differ in the concentration of NH4AC buffer, pH, and organic solvent 
strength. 
The effect of NH4AC buffer concentration: Our first choice of a 
mobile phase was ACN/10 mM NH4AC buffer solution (80:20; v/v). 
The pH of the mobile phase was adjusted to 5.0. The ionic strength of 
the mobile phase started at 10 mM and was increased up to 200 mM 
(Figure 1). As the ionic strength of the mobile phase increased, the 
analysis time decreased and the resolution (Rs) increased among all 
separated drugs. When the concentration of NH4AC was at 20 mM, 
peaks overlapped with no baseline separation between sulfaquinoxaline 
Citation: Ghanem M, Abu-Lafi S, Karaman R, Hallak H (2012) Validated HPLC Method to Simultaneously Determine Amprolium Hydrochloride, 
Sulfaquinoxaline Sodium and Vitamin K3 in A.S.K Powder on ZIC-HILIC Column. Pharmaceut Anal Acta 3:168. doi:10.4172/2153-
2435.1000168
Page 3 of 5
Volume 3 • Issue 7 • 1000168
Pharmaceut Anal Acta
ISSN: 2153-2435 PAA, an open access journal 
sodium and vitamin K3 ingredients. The amprolium hydrochloride 
eluted far away with a total analysis time of about 30 minutes, as shown 
in Figure 2.
 At 75 mM, a new tiny peak was observed between sulfaquinoxaline 
sodium and vitamin K3, which is due to a sulfaquinoxaline related 
impurity (Compound A) [4]. The best separation was achieved at 
mobile phase ionic strength of 200 mM. A resolution of >2.5 was 
achieved between sulfaquinoxaline sodium, its impurity and the 
other active ingredients with a total analysis time of 16 minutes. The 
achieved shorter retention time implies that the interaction is based 
on hydrophilic nature as the ionic strength increased. The positively 
charged ammonium ions in the mobile phase may weaken the 
hydrophilic interaction between the protonated ingredients and the 
stationary phase which result in shortening the retention time.
The effect of the mobile phase pH: A study of the pH effect 
on the resolution was deemed necessary to further optimize the 
separation conditions. The resolution values for all the ingredients 
under investigation were significantly influenced by the variation of the 
mobile phase pH. The pH range tested was from 3.5 up to 7.0. The best 
result was found at a pH between 5.6 and 5.8 (Figure 3). Maximum 
resolution for all ingredients was accomplished at pH 5.7. 
As the pH increased, the retention time of all the ingredients 
slightly increased. The electrostatic interactions between the positively 
charged basic ingredients and the negatively charged surface silanol 
groups increased resulting in an increase of the retention time of all 
active ingredients. Final pH selected for the mobile phase was pH 5.7.
The effect of acetonitrile percentage: The effect of acetonitrile 
organic solvent percentages at fixed NH4AC buffer concentration 
and mobile phase pH of 5.7 on retention and resolution was also 
investigated. It was found that increasing the ratio of ACN in the mobile 
phase resulted in an increase in the retention time and improved the 
peaks resolution. The best separation was achieved when 85% ACN was 
used (Figure 4). 
By increasing the percentage of ACN, the polarity of the mobile 
phase decreased and the hydrophilic interactions between the analytes 
and the stationary were promoted, thereby dramatically increasing the 
retention of the ingredients. 
The effect of acetonitrile on the retention time was systematically 
increased up to 90% ACN. However, when an extra 5% of ACN was 
added, the peak of vitamin K3 eluted in a close proximity to amprolium 
HCl. This probably indicates a sudden disruption in the equilibrium 
coefficient of this compound in the HILIC column. As such ACN of 
85% was selected for the mobile phase. 
The effect of using methanol in addition to ACN as organic solvent 
modifier proved no significant effects on retention time and peaks 
resolution.
The effect of temperature
The effect of a column temperature on peak resolution and tailing 
factor was another chromatographic parameter that was studied during 
the optimization of HPLC methods. Different temperatures such as 
15°C, 20°C, 25°C, 30°C, were evaluated. It was found that varying 
temperatures between 15°C and 30°C had subtle influence on Rs values. 
The best tailing factor obtained was at temperatures of about 25°C and 
30°C.
From all the accumulated results, the optimized mobile phase 
consists of a mixture of 0.2M NH4AC solution and ACN organic 
solvent (15:85; v/v); at pH 5.7 at room temperature. During the method 
development process, the concentrations of the ingredients prepared 
were 20 µg/ml of sulfaquinoxaline sodium, 10 µg/ml of vitamin K3, 
and 20 µg/ml of amprolium hydrochloride. Figure 5 shows typical 
chromatograms obtained for the combined standard mixture using the 
optimized conditions.
Figure 2: Effect of ionic strength on the retention of sulfaquinoxaline sodium 
(Sulf) (20 µg/ml), vitamin K3 (Vit K) (10 µg/ml), and amprolium hydrochloride 
(Ampro) (20 g/ml). Mobile phase consisting of ACN and NH4AC solution (80:20; 
v/v) adjusted to pH of 5.0; flow rate=0.5 ml/min; λ=263 nm; the concentration of 
NH4AC is as shown in the figure.
 
Figure 3: Effect of mobile phase pH on the retention of sulfaquinoxaline sodium 
(Sulf) (20 µg/ml), vitamin K3 (Vit K) (10 µg/ml), and amprolium hydrochloride 
(Ampro) (20 µg/ml). Mobile phase consisting of ACN and 0.2M NH4AC solution 
(80:20; v/v); flow rate=0.5 ml/min; λ=263 nm; the pH of the mobile phase is as 
shown in the figure.
Figure 4: Effect of ACN % on the retention of sulfaquinoxaline sodium (Sulf) (20 
µg/ml), vitamin K3 (Vit K) (10 µg/ml), and amprolium hydrochloride (Ampro) (20 
µg/ml). Mobile phase consisting of ACN and 0.2M NH4AC solution adjusted to 
pH of 5.7; flow rate=0.5 ml/min; λ=263 nm; the ACN% is as shown in the figure.
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Method validation
The validation was carried out according to the ICH/USP guidelines 
[18,19]. Parameters such as specificity; linearity; range; accuracy 
(recovery); precision (repeatability and intermediate precision); 
robustness and stress test were all validated.
Specificity (placebo interference): The chromatograms of the 
placebo solution, standard and test solutions were recorded at the same 
wavelength in order to check the specificity of the method. No peaks 
were observed when the placebo, dextrose monohydrate, that lacks any 
chromophore was injected.
The retention time of the sulfaquinoxaline sodium, amprolium 
hydrochloride, and menadione sample peaks match exactly the peaks 
of the standard solution. No peaks were present at these retention times 
in the placebo chromatogram. Therefore, this method is suitable for the 
identification and quantification of the active ingredients in the A.S.K 
powder.
Linearity and range: Different amounts of sulfaquinoxaline sodium, 
amprolium hydrochloride and menadione (as sodium bisulfite) in the 
range of 60% to 130% of the labeled amount (5 concentration levels/3 
replicates each) were added to A.S.K matrix (dextrose monohydrate).
The linearity for sulfaquinoxaline sodium and amprolium 
hydrochloride in the range of 12 µg/ml to 26 µg/ml was investigated. 
The regression lines demonstrated linearity in the tested range. The 
regression analysis confirmed that the deviation of the y-intercept from 
zero is not significant; and the regression lines were linear with (r) of 
0.9997 for sulfaquinoxaline sodium and (r) of 0.9998 for amprolium 
hydrochloride. 
As to vitamin K3, the linearity was tested in a much smaller 
concentration within the range of 0.12 µg/ml to 0.26 µg/ml. The 
regression line was linear with (r) of 0.9983 (Table 1).
Accuracy (recovery): The different concentrations of the 
ingredients mixture were added to placebo matrix and the accuracy was 
measured as reflected by recovery. The data obtained for the evaluation 
of the linearity were used. The accuracy as reflected from recovery data 
and statistical evaluation for assay of the three active ingredients is listed 
in table 2. The recovery data of sulfaquinoxaline sodium, amprolium 
hydrochloride and vitamine K3 showed results between 97.8% and 
102% with RSD of less than 2.0% and therefore the acceptance criteria 
were fulfilled.
Precision
Repeatability: One laboratory analyst carried out the assay of 
sulfaquinoxaline sodium, amprolium hydrochloride and vitamin K3 on 
six determinations of homogeneous sample of A.S.K powder at 100% 
level of the test concentration with the same analytical equipment at 
the same day. The repeatability results of the peak areas and statistical 
evaluation for assay of the three active ingredients are listed in table 3.
Intermediate precision (ruggedness): Two laboratory analysts 
carried out the assay of sulfaquinoxaline sodium, amprolium 
hydrochloride and vitamin K3 on twelve homogeneous samples of 
A.S.K powder at 100% level of the final test concentration with different 
analytical equipments at different days. The assay results and statistical 
evaluation for assay of the three active ingredients is listed in table 3. 
The RSD percentage values showed that the results of the assay of 
the three active ingredients are within a suitable intermediate precision 
for the specified range. 
Robustness: Robustness of the investigated HILIC-HPLC new 
method included five deliberate variations to some chromatographic 
parameters as summarized in Table 4. The modifications include 
different mobile phase flow rates of 0.45, 0.50, and 0.55 ml/min and 
three different column temperatures in the range 23-27°C. Ammonium 
acetate buffer in the range of (±3 of the nominal value) were also 
investigated. Three column batches filled with the prescribed stationary 
phases were studied. Finally three different pH values of the mobile 
Figure 5: Typical chromatogram of standard mixture of sulfaquinoxaline sodium 
(1), vitamin K3 (2) and amprolium hydrochloride (3); Column, a ZIC-HILIC column 
(25.0 cm long × 4.6 mm i.d.) with particle size of 5 μm protected with a ZIC-HILIC 
guard column (20 mm × 2.1 mm, 5 µm); Mobile phase consisting of ACN and 
0.2M NH4AC solution (85:15; v/v) at pH 5.7; flow rate 0.5 ml/min; λ at 263 nm; 
column temperature of 25°C; Autosampler temperature of 15°C. Peak 4 is due to 
sulfaquinoxaline impurity A.
Active ingredient Regression equation
Correlation 
coefficient 
(R)
Linear range (µg/ml)
60% to 130% of labeled 
amount
Amprolium HCl y = 269332x + 62202 0.9998 (12-26)
Sulfaquinoxaline 
sodium y = 597297x - 11291 0.9997 (12-26)
Vitamin K3 y = 555682x - 644.34 0.9983 (0.12-0.26)
Table 1: Linear ranges of the three active ingredients: amprolium HCl, 
sulfaquinoxaline sodium and vitamin K3 (menadione sodium bisulfite).
Active ingredient Amount added (level %) Average recovery (%) RSD (%)
Sulfaquinoxaline 
sodium
12µg/ml (60%) 99.2 0.25
16 µg/ml (80%) 99.7 0.49
20 µg/ml (100%) 98.3 0.21
24 µg/ml (120%) 99.2 0.35
26 µg/ml (130%) 99.5 0.06
Amprolium HCl
12 µg/ml (60%) 98.9 0.35
16 µg/ml (80%) 98.7 0.10
20 µg/ml (100%) 99.7 0.12
24 µg/ml (120%) 98.2 0.12
26 µg/ml (130%) 98.1 0.06
Vitamin K3
0.12 µg/ml (60%) 102.0 0.21
0.16 µg/ml (80%) 99.5 0.06
0.20 µg/ml (100%) 97.8 0.68
0.24 µg/ml (120%) 100.5 0.57
0.26 µg/ml (130%) 101.5 0.32
Table 2: Average recoveries, RSD values at five concentration levels of spiking 
(n=3).
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phase at 5.6, 5.7, and 5.8 were tested. The RSD percentage values showed 
no significant change in the final assay results of each of the above three 
active ingredients using the five variations.
Conclusion
The HPLC method we have developed for quantitative 
determination of sulfaquinoxaline sodium, vitamin K3 sodium bisulfite, 
and amprolium hydrochloride in A.S.K powder was evaluated over the 
linearity, precision, accuracy, specificity, ruggedness and robustness. 
All the assay validation results were within the allowed specifications 
of ICH/USP guidelines. The developed method is rapid, selective, 
requires a simple sample preparation procedure, and represents a good 
procedure for the simultaneous determination of the combined drugs 
in A.S.K formulation. 
In summary, the proposed method can be used for the drug analysis 
in routine quality control of A.S.K formulation. 
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